Cargando…
NKG2A inhibits TH2 cell effector function in vitro
BACKGROUND: We previously reported that NKG2A, a key inhibitory ligand for HLA-E, is expressed on activated TH2 but not TH1 cells. Here we measured cytokine expression in human ex vivo TH2 cells upon activation with anti-CD3/28 and challenge with an NKG2A-specific agonist. METHODS: TH2 cells were pu...
Autores principales: | Freishtat, Robert J, Mojgani, Bahar, Nazemzadeh, Maryam, Nagaraju, Kanneboyina, Hoffman, Eric P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174509/ https://www.ncbi.nlm.nih.gov/pubmed/17927829 http://dx.doi.org/10.1186/1471-2466-7-14 |
Ejemplares similares
-
NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer
por: Smyth, Mark J., et al.
Publicado: (2004) -
Platelets Induce Apoptosis during Sepsis in a Contact-Dependent Manner That Is Inhibited by GPIIb/IIIa Blockade
por: Sharron, Matthew, et al.
Publicado: (2012) -
NKG2A silencing in effector cells to improve effectivity of cell based therapeutics
por: Figueiredo, C, et al.
Publicado: (2009) -
NKG2D signaling certifies effector CD8 T cells for memory formation
por: Perez, Cynthia, et al.
Publicado: (2019) -
Monalizumab: inhibiting the novel immune checkpoint NKG2A
por: van Hall, Thorbald, et al.
Publicado: (2019)